These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2258132)

  • 21. Report on a 3-year follow-up zidovudine (AZT) treatment in a group of HIV-positive patients with congenital clotting disorders.
    Sartori MT; Mares M; Zerbinati P; Stocco D; Girolami A
    Haematologia (Budap); 1994; 26(1):17-27. PubMed ID: 7959371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of zidovudine compared with didanosine on health status and functioning in persons with advanced HIV infection and a varying duration of prior zidovudine therapy. AIDS Clinical Trials Group 116/117 Study Group.
    Bozzette SA; Kanouse DE; Duan N; Berry S; Richman DD
    Antivir Ther; 1996 Jan; 1(1):21-32. PubMed ID: 11322256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of HIV disease in 1993/1994.
    Fischl MA
    AIDS Clin Rev; 1993-1994; ():167-87. PubMed ID: 8217898
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of HIV infection--progress in perspective.
    Corey L; Fleming TR
    N Engl J Med; 1992 Feb; 326(7):484-6. PubMed ID: 1732776
    [No Abstract]   [Full Text] [Related]  

  • 25. Zidovudine + lamivudine: new preparation. Fewer tablets required.
    Prescrire Int; 1999 Apr; 8(40):39-40. PubMed ID: 10848057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zidovudine: clinical experience in symptomatic HIV disease.
    Fischl MA
    AIDS Clin Rev; 1989; ():221-42. PubMed ID: 2488693
    [No Abstract]   [Full Text] [Related]  

  • 27. Longitudinal melanonychia induced by 3'-azidodeoxythymidine. Report of 9 cases.
    Tosti A; Gaddoni G; Fanti PA; D'Antuono A; Albertini F
    Dermatologica; 1990; 180(4):217-20. PubMed ID: 2358102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Zidovudine therapy in 141 patients with symptoms of HIV infection; a multicenter study].
    Perenboom R; Reiss P; Danner SA; van 't Wout JW
    Ned Tijdschr Geneeskd; 1990 Jan; 134(3):120-4. PubMed ID: 2405287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [HIV infection--current possibilities in antiviral therapy].
    Hirschel B
    Ther Umsch; 1994 Aug; 51(8):545-50. PubMed ID: 7940411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zidovudine use in pregnancy.
    Eldridge RR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):208-9. PubMed ID: 7749802
    [No Abstract]   [Full Text] [Related]  

  • 31. The efficacy of combined zidovudine and lamivudine compared with that of combined zidovudine, lamivudine and nelfinavir in asymptomatic and early symptomatic HIV-infected children.
    Moolasart P; Likanonsakul S
    Southeast Asian J Trop Med Public Health; 2002 Jun; 33(2):280-7. PubMed ID: 12236426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zidovudine and the quality of life.
    Berman DS; Wenglin BD
    N Engl J Med; 1994 Aug; 331(5):332-3. PubMed ID: 8022458
    [No Abstract]   [Full Text] [Related]  

  • 33. A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection.
    Vella S; Lazzarin A; Carosi G; Sinicco A; Armignacco O; Angarano G; Andreoni M; Tambussi G; Chiodera A; Floridia M; Scaccabarozzi S; Facey K; Duncan I; Boudes P; Bragman K
    Antivir Ther; 1996 Aug; 1(3):129-40. PubMed ID: 11322246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of combined zidovudine and didanosine therapy in early asymptomatic primary HIV-1 infection.
    Khajotia RR; Feigley CE; Lee E; Gu J
    AIDS; 1998 Jan; 12(2):222-4. PubMed ID: 9468376
    [No Abstract]   [Full Text] [Related]  

  • 35. Early zidovudine and survival in HIV infection.
    Hirschel B
    N Engl J Med; 1992 Sep; 327(11):814; author reply 815-6. PubMed ID: 1501667
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacotherapy of HIV. APhA Editorial Board on Pharmaceutical Care for Patients with HIV Infection.
    Am Pharm; 1994 Feb; NS34(2):60-9; quiz 69-70. PubMed ID: 8166046
    [No Abstract]   [Full Text] [Related]  

  • 37. Should the dosage of zidovudine be adjusted in HIV-infected patients with impaired renal function?
    Amantea MA
    Am J Hosp Pharm; 1990 Mar; 47(3):618-9. PubMed ID: 2316548
    [No Abstract]   [Full Text] [Related]  

  • 38. Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection.
    Yamamoto Y; Yasuoka A; Yasuoka C; Genka I; Teruya K; Kikuchi Y; Tachikawa N; Oka S
    Jpn J Infect Dis; 2000 Dec; 53(6):244-5. PubMed ID: 11227023
    [No Abstract]   [Full Text] [Related]  

  • 39. [Lamivudine-zidovudine combination treatment].
    Mörike EM
    Dtsch Med Wochenschr; 1996 Oct; 121(40):A8, A11. PubMed ID: 8925752
    [No Abstract]   [Full Text] [Related]  

  • 40. For HIV patients survival increases the risk of lymphoma.
    Pluda J; Yarchoan R
    RN; 1990 Nov; 53(11):144. PubMed ID: 2267505
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.